HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard E Champlin Selected Research

Etoposide (VP 16)

1/2019Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
1/2017A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
4/2005Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard E Champlin Research Topics

Disease

82Neoplasms (Cancer)
01/2024 - 01/2002
72Graft vs Host Disease (Graft-Versus-Host Disease)
03/2024 - 01/2002
58Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 03/2002
42Multiple Myeloma
05/2024 - 04/2004
34Hematologic Neoplasms (Hematological Malignancy)
03/2024 - 01/2002
30Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2023 - 08/2004
28Lymphoma (Lymphomas)
01/2023 - 04/2003
24Infections
01/2021 - 11/2002
21Leukemia
10/2023 - 11/2004
17Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2022 - 03/2002
15BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2016 - 01/2002
12Bronchiolitis Obliterans Syndrome
01/2024 - 02/2005
12Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 02/2004
10Residual Neoplasm
12/2023 - 08/2014
9Disease Progression
01/2021 - 03/2003
9Breast Neoplasms (Breast Cancer)
01/2013 - 05/2003
8Myeloid Leukemia (Leukemia, Myelocytic)
10/2023 - 11/2008
8Hodgkin Disease (Hodgkin's Disease)
01/2021 - 06/2006
7Primary Myelofibrosis (Myelosclerosis)
12/2023 - 04/2010
7Philadelphia Chromosome
11/2022 - 08/2013
7Neutropenia
11/2022 - 02/2005
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 09/2008
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 01/2021
5Hemorrhagic Cystitis
01/2021 - 08/2009
5Mycoses (Diseases, Fungus)
12/2020 - 02/2005
5Chromosome Aberrations (Chromosome Abnormalities)
01/2018 - 09/2007
4COVID-19
12/2023 - 01/2021
4Pathologic Complete Response
11/2020 - 11/2014
4Respiratory Syncytial Virus Infections
08/2014 - 09/2010
4Respiratory Tract Infections (Respiratory Tract Infection)
08/2014 - 11/2012
4Aplastic Anemia (Anemia, Hypoplastic)
02/2014 - 05/2007
3Fever (Fevers)
11/2022 - 02/2005
3Frailty
03/2020 - 04/2007
3Immunoglobulin Light-chain Amyloidosis
11/2018 - 08/2015
3Renal Insufficiency (Renal Failure)
01/2018 - 07/2009
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2009 - 12/2003

Drug/Important Bio-Agent (IBA)

36Busulfan (Busulfex)FDA Link
12/2023 - 01/2002
34Melphalan (Alkeran)FDA LinkGeneric
11/2022 - 10/2002
33Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2024 - 01/2002
33fludarabineIBA
12/2023 - 10/2002
19Tacrolimus (Prograf)FDA LinkGeneric
12/2023 - 11/2003
18AntigensIBA
10/2022 - 03/2002
16Chimeric Antigen ReceptorsIBA
01/2024 - 10/2010
14Methotrexate (Mexate)FDA LinkGeneric
12/2023 - 11/2003
11Rituximab (Mabthera)FDA Link
01/2021 - 01/2004
10Clofarabine (Clolar)FDA Link
01/2022 - 06/2011
9CytokinesIBA
10/2023 - 11/2002
8DNA (Deoxyribonucleic Acid)IBA
11/2018 - 05/2012
8Antiviral Agents (Antivirals)IBA
01/2018 - 09/2006
8GemcitabineFDA Link
11/2017 - 03/2012
7Lenalidomide (CC 5013)FDA Link
10/2023 - 03/2013
7Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2004
7NucleosidesIBA
10/2016 - 05/2012
6Bortezomib (Velcade)FDA Link
01/2022 - 05/2012
6Alkylating AgentsIBA
11/2018 - 05/2012
5Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2024 - 03/2016
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 03/2007
5Cytarabine (Cytosar-U)FDA LinkGeneric
01/2019 - 04/2005
5Imatinib Mesylate (Gleevec)FDA Link
08/2013 - 03/2003
4Interleukin-15 (Interleukin 15)IBA
01/2024 - 11/2016
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2023 - 12/2003
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2023 - 12/2003
4RNA (Ribonucleic Acid)IBA
01/2023 - 09/2012
4HLA-DPB1 antigen (HLA DPB1)IBA
01/2023 - 01/2018
4HLA-A Antigens (HLA-A)IBA
01/2023 - 03/2002
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 02/2016
4SteroidsIBA
01/2022 - 11/2002
4Tyrosine Kinase InhibitorsIBA
01/2021 - 06/2011
4Calcineurin InhibitorsIBA
10/2019 - 01/2015
4Carmustine (FIVB)FDA Link
01/2019 - 11/2004
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2018 - 05/2007
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2016 - 02/2006
4HLA Antigens (Human Leukocyte Antigens)IBA
12/2014 - 03/2002
3VorinostatFDA Link
01/2022 - 05/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2006
3Etoposide (VP 16)FDA LinkGeneric
01/2019 - 04/2005
3DecitabineFDA Link
11/2018 - 03/2010
3Proteasome InhibitorsIBA
11/2018 - 03/2016
3Immunomodulating AgentsIBA
11/2018 - 03/2016
3fms-Like Tyrosine Kinase 3IBA
04/2017 - 11/2014
3Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
03/2016 - 11/2004
3InterferonsIBA
01/2015 - 02/2005
3Ribavirin (Virazole)FDA LinkGeneric
05/2014 - 11/2012
3Monoclonal AntibodiesIBA
06/2012 - 11/2009

Therapy/Procedure

91Hematopoietic Stem Cell Transplantation
05/2024 - 01/2002
78Stem Cell Transplantation
05/2024 - 01/2002
72Transplantation
12/2023 - 01/2002
68Therapeutics
07/2023 - 07/2002
34Drug Therapy (Chemotherapy)
07/2023 - 05/2003
29Cell Transplantation
02/2024 - 10/2008
14Homologous Transplantation
01/2019 - 10/2002
9Autologous Transplantation
01/2024 - 06/2004
9Immunotherapy
01/2023 - 05/2010
8Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2014 - 03/2002
7Haploidentical Transplantation
12/2019 - 03/2012
5Investigational Therapies (Experimental Therapy)
11/2016 - 04/2006
3Radiotherapy
01/2023 - 06/2009
3Salvage Therapy
01/2018 - 06/2004
3Blood Component Removal (Apheresis)
01/2017 - 07/2011
3Induction Chemotherapy
12/2016 - 09/2008